Table 2 Percentage of patients undergoing one or more additional tests in relation to the underlying pathology in patients with LANSS ≥ 12 (n = 1,163)
Number of tests | |||||||
|---|---|---|---|---|---|---|---|
Pathology | 0 | 1 | 2 | 3 | 4 | 5 | 6 |
Diabetic neuropathy (n = 89) | 6.7 | 46.1 | 19.1 | 10.1 | 11.2 | 6.7 | 0.0 |
Cancer (n = 27) | 0.0 | 14.8 | 7.4 | 29.6 | 33.3 | 11.1 | 3.7 |
Lumbar problem (n = 84) | 5.9 | 9.5 | 19.1 | 35.7 | 20.2 | 9.5 | 0.0 |
Osteoporosis (n = 3) | 0.0 | 0.0 | 33.3 | 66.7 | 0.0 | 0.0 | 0.0 |
PHN (n = 98) | 55.1 | 19.4 | 14.3 | 9.2 | 0.0 | 1.0 | 1.0 |
Multiple sclerosis (n = 22) | 9.1 | 27.27 | 18.18 | 22.73 | 13.64 | 9.09 | 0.00 |
Post-traumatic lesion (n = 62) | 6.4 | 19.3 | 19.3 | 17.7 | 20.9 | 16.1 | 0.0 |
Thalamic syndrome (n = 1) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 |
CRPS (n = 51) | 11.8 | 13.7 | 25.5 | 17.65 | 23.53 | 7.8 | 0.0 |
Alcohol (n = 17) | 11.8 | 29.4 | 29.4 | 11.76 | 17.65 | 0.0 | 0.0 |
Syringomyelia (n = 6) | 16.7 | 50.0 | 16.7 | 0.00 | 0.00 | 16.7 | 0.0 |
Post-surgical lesion (n = 34) | 8.8 | 17.6 | 26.5 | 20.6 | 14.7 | 5.9 | 5.9 |
CCS (n = 31) | 3.2 | 74.2 | 16.1 | 3.2 | 3.2 | 0.0 | 0.0 |
Osteoarthritis (n = 17) | 11.8 | 5.9 | 23.5 | 17.6 | 23.5 | 11.8 | 5.9 |
Post-CVA (n = 24) | 12.5 | 25.0 | 37.5 | 16.7 | 4.2 | 4.2 | 0.0 |
Others (n = 119) | 13.4 | 25.2 | 21.8 | 20.2 | 10.9 | 6.7 | 1.7 |